Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
8.07
-0.25 (-3.00%)
At close: Mar 24, 2026, 4:00 PM EDT
8.23
+0.16 (1.98%)
After-hours: Mar 24, 2026, 6:17 PM EDT

Kura Oncology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
149.1224.4637.3251.890.67
Short-Term Investments
518.14502.93386.64386.18427.29
Cash & Short-Term Investments
667.24727.4423.96437.99517.96
Cash Growth
-8.27%71.57%-3.20%-15.44%-18.21%
Accounts Receivable
8.82.06---
Inventory
0.41----
Other Current Assets
32.2115.378.528.444.33
Total Current Assets
708.66744.83432.48446.43522.29
Net Property, Plant & Equipment
15.167.498.686.388.25
Other Long-Term Assets
14.547.857.63.53.52
Total Assets
738.36760.16448.94456.31534.05
Accounts Payable
5.021.4733.7621.7420.19
Accrued Expenses
61.748.48---
Current Portion of Long-Term Debt
-2.61---
Current Portion of Leases
1.281.881.512.322.26
Unearned Revenue
48.9824.27---
Total Current Liabilities
116.9778.7135.2624.0622.46
Long-Term Debt
9.716.929.339.16-
Long-Term Leases
9.475.196.362.554.61
Other Long-Term Liabilities
428.07255.70.710.270.38
Total Long-Term Liabilities
447.25267.8116.411.974.99
Total Liabilities
564.23346.5251.6636.0327.44
Common Stock
0.010.010.010.010.01
Additional Paid-in Capital
1,3471,3081,120997.11941.36
Accumulated Other Comprehensive Income
1.020.76-1.27-8.03-1.79
Retained Earnings
-1,174-895.42-721.44-568.81-432.97
Shareholders' Equity
174.14413.64397.27420.28506.61
Total Liabilities & Equity
738.36760.16448.94456.31534.05
Total Debt
20.4616.5917.214.026.88
Net Cash (Debt)
646.78710.8406.76423.96511.09
Net Cash Growth
-9.01%74.75%-4.06%-17.05%-17.62%
Net Cash Per Share
7.388.255.556.337.70
Book Value
174.14413.64397.27420.28506.61
Book Value Per Share
1.994.805.436.277.64
Tangible Book Value
174.14413.64397.27420.28506.61
Tangible Book Value Per Share
1.994.805.436.277.64
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q